A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Parecoxib Impurity 15 | CAS 26306-06-9 - Request Quote

Picture of Parecoxib Impurity 15

Parecoxib Impurity 15

SZ CAT No:SZ-P047018
CAS No
26306-06-9
Mol.F.
C14H13NO
Mol.Wt.
211.3
Inv. Status
In Stock

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Parecoxib Impurity 15 is chemically (E)-1,2-diphenylethan-1-one oxime. Parecoxib Impurity 15 is supplied with detailed characterization data compliant with regulatory guideline. Parecoxib Impurity 15 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Parecoxib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 26306-06-9

Purchase 26306-06-9

Order 26306-06-9

Enquire 26306-06-9

price of 26306-06-9

26306-06-9 Supplier

26306-06-9 Manufacturer

26306-06-9 Exporter

buy high quality Parecoxib Impurity 15

Purchase Parecoxib Impurity 15

Parecoxib Impurity 15 suppliers

Parecoxib Impurity 15 manufacturers

Parecoxib Impurity 15 price

Order Parecoxib Impurity 15

Enquire Parecoxib Impurity 15

Parecoxib Impurity 15 cost

Parecoxib Impurity 15 Supplier

Parecoxib Impurity 15 Distributor

Parecoxib Impurity 15 for Method Validation

Parecoxib Reference Standard

Parecoxib Impurity 15 for ANDA Filing

Parecoxib Impurity 15 for Forced Degradation Studies

Parecoxib Impurity 15 Identification Standards

Parecoxib Impurity 15 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,